Abstract
Aims
To describe the distribution and changes of different metabolic/obese phenotypes among more than 22,000 male elderly in China, and also explore the association with diabetes incidence.
Methods
A cohort study based on 22,276 male elderly was conducted in Beijing, from 2009 to 2013. Multiple Cox model was used to calculate the relative risk.
Results
There were only 53.8% of total participants who kept the same phenotype for the 5 years. On the whole, participants with metabolically unhealthy phenotypes had higher relative risks (RRs) than those with metabolically healthy phenotypes. RRs for diabetes showed an increasing trend along with metabolic abnormalities (p < 0.001). However, no statistically significant difference was found across different obese status with the same number of metabolic abnormalities. Changes of metabolic/obese status also showed the same trend. Those who had kept metabolic unhealthy had the highest RRs for diabetes incidence, which was higher than those who kept obesity.
Conclusions
Both metabolically healthy obesity and metabolically unhealthy normal weight phenotypes had an increased risk for diabetes incidence, and metabolic abnormalities might have more influence on diabetes than obesity itself. Changes of metabolic/obese status also had an important impact on diabetes incidence.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- DBP:
-
Diastolic blood pressure
- FBG:
-
Fasting blood glucose
- HDL-C:
-
High-density lipoprotein cholesterol
- LDL-C:
-
Low-density lipoprotein cholesterol
- MHNW:
-
Metabolically healthy normal weight
- MHO:
-
Metabolically healthy obesity
- MHOW:
-
Metabolically healthy overweight
- MUNW:
-
Metabolically unhealthy normal weight
- MUO:
-
Metabolically unhealthy obesity
- MUOW:
-
Metabolically unhealthy overweight
- RR:
-
Relative risk
- SBP:
-
Systolic blood pressure
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- 2hPG:
-
Two hours plasma glucose
References
R. Viner, B. White, D. Christie, Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden. Lancet 389, 2252–2260 (2017)
S.L. Hardoon, R.W. Morris, M.C. Thomas, S.G. Wannamethee, L.T. Lennon, P.H. Whincup, Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men. Diabetes Care 33, 1494–1496 (2010)
A. Abdullah, A. Peeters, M.D. Courten, J. Stoelwinder, The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res. Clin. Pract. 89, 309–319 (2010)
L.C. Hwang, C.H. Bai, C.A. Sun, C.J. Chen, Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac. J. Clin. Nutr. 21, 227–233 (2012)
A.D. Karelis, D.H. St-Pierre, F. Conus, R. Rabasa-Lhoret, E.T. Poehlman, Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89, 2569–2575 (2004)
Y. Chang, S. Ryu, Y. Choi, Y. Zhang, J. Cho, M.J. Kwon, Y.Y. Hyun, K.B. Lee, H. Kim, H.S. Jung, K.E. Yun, J. Ahn, S. Rampal, D. Zhao, B.S. Suh, E.C. Chung, H. Shin, R. Pastor-Barriuso, E. Guallar, Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann. Intern. Med. 164, 305–312 (2016)
Y. Chang, B.K. Kim, K.E. Yun, J. Cho, Y. Zhang, S. Rampal, D. Zhao, H.S. Jung, Y. Choi, J. Ahn, J.A. Lima, H. Shin, E. Guallar, S. Ryu, Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679–2686 (2014)
N. Eckel, K. Mühlenbruch, K. Meidtner, H. Boeing, N. Stefan, M.B. Schulze, Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metab. Clin. Exp. 64, 862–871 (2015)
A. Goday, E. Calvo, L.A. Vázquez, E. Caveda, T. Margallo, C. Catalina-Romero, J. Reviriego, Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health 16, 248 (2016)
H.K. Nan, A.S. Ji, H. Cho, J.H. Seo, J.H. Yu, H.J. Yoo, S.G. Kim, K.M. Choi, S.H. Baik, D.S. Choi, C. Shin, N.H. Cho, Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: the Korean genome and epidemiology study. Medicine 95, e3384 (2016)
M. Liu, J. Wang, J. Zeng, X. Cao, Y. He, Association of NAFLD with diabetes and the impact of BMI changes: a 5 years’ cohort study based on 18507 elderly. J. Clin. Endocrinol. Metab. 102, 1309 (2017)
K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120, 1640 (2009)
G. Calori, G. Lattuada, L. Piemonti, M.P. Garancini, F. Ragogna, M. Villa, S. Mannino, P. Crosignani, E. Bosi, L. Luzi, G. Ruotolo, G. Perseghin, Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210 (2011)
E.J. Rhee, M.K. Lee, J.D. Kim, W.S. Jeon, J.C. Bae, S.E. Park, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS ONE 9, e98369 (2014)
S.L. Appleton, C.J. Seaborn, R. Visvanathan, C.L. Hill, T.K. Gill, A.W. Taylor, R.J. Adams, North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype. Diabetes Care 36, 2388 (2013)
G.M. Hinnouho, S. Czernichow, A. Dugravot, H. Nabi, E.J. Brunner, M. Kivimaki, A. Singh-Manoux, Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur. Heart J. 36, 551–559 (2015)
Y. Heianza, K. Kato, S. Kodama, A. Suzuki, S. Tanaka, O. Hanyu, K. Sato, H. Sone, Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study. Obesity 22, 2420–2425 (2014)
K. Aung, C. Lorenzo, M.A. Hinojosa, S.M. Haffner, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J. Clin. Endocrinol. Metab. 99, 462–468 (2014)
C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013)
L.L. Roberson, E.C. Aneni, W. Maziak, A. Agatston, T. Feldman, M. Rouseff, T. Tran, M. Blaha, R. Santos, A. Sposito, M. Al-Mallah, R. Blankstein, M. Budoff, K. Nasir, Beyond BMI: the “metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—a systematic review. BMC Public Health 14, 14 (2014)
F. Badoud, M. Perreault, M.A. Zulyniak, D.M. Mutch, Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 29, 748–758 (2015)
N. Freemantle, J. Holmes, A. Hockey, S. Kumar, How strong is the association between abdominal obesity and the incidence of type 2 diabetes?. Int. J. Clin. 62, 1391–1396 (2008)
M.J. Mcneely, J.B. Shofer, D.L. Leonetti, W.Y. Fujimoto, E.J. Boyko, Associations among visceral fat, all-cause mortality, and obesity-related mortality in Japanese Americans. Diabetes Care 35(2), 296–298 (2012)
Funding
This study is supported by research grants from Beijing Nova Program (Z181100006218085), Opening Foundation of State Key Laboratory of Kidney Diseases (KF-01-115), Opening Foundation of National Clinical Research Center of Geriatrics (NCRCG-PLAGH-2017017), National Natural Science Foundation of China (81703285), Beijing Natural Science Foundation (7174350), Beijing Municipal Science and Technology Commission (Z161100005016021), Military Fund (15BJZ41, 17BJZ51). The views and opinions expressed in this paper are those of the authors and do not necessarily reflect the official position of the study sponsors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. And this study protocol had been approved by the Ethics Committees of Chinese PLA General Hospital (EC0411-2001).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Liu, M., Tang, R., Wang, J. et al. Distribution of metabolic/obese phenotypes and association with diabetes: 5 years’ cohort based on 22,276 elderly. Endocrine 62, 107–115 (2018). https://doi.org/10.1007/s12020-018-1672-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1672-7